Evolent Health (EVH) PT Raised to $7 at Truist Securities
Tweet
Share
E-mailGet Alerts EVH Hot Sheet
Price: $3.62 --0%
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 48
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 48
Join SI Premium – FREE
Truist Securities analyst Jailendra Singh raised the price target on Evolent Health (NYSE: EVH) to $7.00 (from $6.00) while maintaining a Buy rating.
You May Also Be Interested In
- TransPerfect wins telephonic interpretation contract with Evolent
- Kinross Gold (K:CN) (KGC) PT Lowered to Cdn$47 at Canaccord
- Fleury SA (FLRY3:BZ) PT Raised to R$20 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
